{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:54:52Z","timestamp":1794862492773,"version":"4.9.1"},"reference-count":182,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taipei Tzu Chi Hospital, Tzu Chi Buddhist Health Foundation","award":["TCRD-TPE-111-02"],"award-info":[{"award-number":["TCRD-TPE-111-02"]}],"id":[{"id":"https:\/\/ror.org\/00q017g63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Taipei Tzu Chi Hospital, Tzu Chi Buddhist Health Foundation","award":["WXL-TPE-111-1"],"award-info":[{"award-number":["WXL-TPE-111-1"]}],"id":[{"id":"https:\/\/ror.org\/00q017g63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Wu Xiulan Education Foundation","award":["TCRD-TPE-111-02"],"award-info":[{"award-number":["TCRD-TPE-111-02"]}]},{"name":"Wu Xiulan Education Foundation","award":["WXL-TPE-111-1"],"award-info":[{"award-number":["WXL-TPE-111-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Patients with chronic kidney disease (CKD) often experience a high accumulation of protein-bound uremic toxins (PBUTs), specifically indoxyl sulfate (IS) and p-cresyl sulfate (pCS). In the early stages of CKD, the buildup of PBUTs inhibits bone and muscle function. As CKD progresses, elevated PBUT levels further hinder bone turnover and exacerbate muscle wasting. In the late stage of CKD, hyperparathyroidism worsens PBUT-induced muscle damage but can improve low bone turnover. PBUTs play a significant role in reducing both the quantity and quality of bone by affecting osteoblast and osteoclast lineage. IS, in particular, interferes with osteoblastogenesis by activating aryl hydrocarbon receptor (AhR) signaling, which reduces the expression of Runx2 and impedes osteoblast differentiation. High PBUT levels can also reduce calcitriol production, increase the expression of Wnt antagonists (SOST, DKK1), and decrease klotho expression, all of which contribute to low bone turnover disorders. Furthermore, PBUT accumulation leads to continuous muscle protein breakdown through the excessive production of reactive oxygen species (ROS) and inflammatory cytokines. Interactions between muscles and bones, mediated by various factors released from individual tissues, play a crucial role in the mutual modulation of bone and muscle in CKD. Exercise and nutritional therapy have the potential to yield favorable outcomes. Understanding the underlying mechanisms of bone and muscle loss in CKD can aid in developing new therapies for musculoskeletal diseases, particularly those related to bone loss and muscle wasting.<\/jats:p>","DOI":"10.3390\/biomedicines11072076","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T03:03:25Z","timestamp":1690167805000},"page":"2076","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-8925","authenticated-orcid":false,"given":"Kuo-Chin","family":"Hung","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Min-Sheng General Hospital, Taoyuan City 330, Taiwan"},{"name":"Department of Pharmacy, Tajen University, Pingtung 907, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Cheng","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Min-Sheng General Hospital, Taoyuan City 330, Taiwan"},{"name":"Department of Medical Education and Clinical Research, Min-Sheng General Hospital, Taoyuan City 330, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lien","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Min-Sheng General Hospital, Taoyuan City 330, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Min-Sheng General Hospital, Taoyuan City 330, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Tser","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Taoyuan Armed Forces General Hospital Hsinchu Branch, Hsinchu City 300, Taiwan"},{"name":"Department of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan"},{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keong","family":"Chong","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Min-Sheng General Hospital, Taoyuan City 330, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-144X","authenticated-orcid":false,"given":"Ching-Hsiu","family":"Peng","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and School of Medicine, Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-8560","authenticated-orcid":false,"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and School of Medicine, Tzu Chi University, Hualien 970, Taiwan"},{"name":"Division of Nephrology, Department of Medicine, Fu-Jen Catholic University Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan"},{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00467-008-0762-9","article-title":"What is new in uremic toxicity?","volume":"23","author":"Vanholder","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11914-017-0366-z","article-title":"Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics","volume":"15","author":"McNerny","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/kisup.2013.93","article-title":"Uremic osteoporosis","volume":"3","author":"Kazama","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00467-019-04331-6","article-title":"Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease","volume":"34","author":"Holle","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Holle, J., Kirchner, M., Okun, J., Bayazit, A.K., Obrycki, L., Canpolat, N., Bulut, I.K., Azukaitis, K., Duzova, A., and Ranchin, B. (2020). Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0240446"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Iwasaki","year":"2007","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cca.2018.05.057","article-title":"Effect of uremic toxin-indoxyl sulfate on the skeletal system","volume":"484","author":"Liu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, Y.H., Kwak, K.A., Gil, H.W., Song, H.Y., and Hong, S.Y. (2013). Indoxyl sulfate promotes apoptosis in cultured osteoblast cells. BMC Pharmacol. Toxicol., 14.","DOI":"10.1186\/2050-6511-14-60"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5049\/EBP.2021.19.2.29","article-title":"Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment","volume":"19","author":"Kim","year":"2021","journal-title":"Electrolyte Blood Press."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2016.03.017","article-title":"Bone loss in chronic kidney disease: Quantity or quality?","volume":"87","author":"Zheng","year":"2016","journal-title":"Bone"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Drueke","year":"2016","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"Huang","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es e Silva, A.C., Oliveira, E.A., Cheung, W.W., and Mak, R.H. (2023). Redox Signaling in Chronic Kidney Disease-Associated Cachexia. Antioxidants, 12.","DOI":"10.3390\/antiox12040945"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Umakanthan, M., Li, J.W., Sud, K., Duque, G., Guilfoyle, D., Cho, K., Brown, C., Boersma, D., and Gangadharan Komala, M. (2021). Prevalence and Factors Associated with Sarcopenia in Patients on Maintenance Dialysis in Australia-A Single Centre, Cross-Sectional Study. Nutrients, 13.","DOI":"10.3390\/nu13093284"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s42003-021-02546-8","article-title":"Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice","volume":"4","author":"Adhikari","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15141","DOI":"10.1038\/s41598-021-94565-y","article-title":"The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia","volume":"11","author":"Cheung","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","article-title":"Pathophysiological mechanisms leading to muscle loss in chronic kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32084","DOI":"10.1038\/srep32084","article-title":"Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1","volume":"6","author":"Enoki","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Romagnoli, C., Zonefrati, R., Lucattelli, E., Innocenti, M., Civinini, R., Iantomasi, T., and Brandi, M.L. (2023). In Vitro Effects of PTH (1-84) on Human Skeletal Muscle-Derived Satellite Cells. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041017"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00223-019-00612-2","article-title":"Effects of Elevated Parathyroid Hormone Levels on Muscle Health, Postural Stability and Quality of Life in Vitamin D-Insufficient Healthy Women: A Cross-Sectional Study","volume":"105","author":"Bislev","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-80-2-182","article-title":"Neuromuscular disease in primary hyperparathyroidism","volume":"80","author":"Patten","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E1465","DOI":"10.1152\/ajpendo.00487.2006","article-title":"Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism","volume":"292","author":"Reppe","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.archger.2015.01.005","article-title":"Secondary hyperparathyroidism and its relationship with sarcopenia in elderly women","volume":"60","author":"Szejnfeld","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1210\/jc.2003-030604","article-title":"Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam","volume":"88","author":"Visser","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MCO.0000000000000357","article-title":"Parathyroid hormone stimulates adipose tissue browning: A pathway to muscle wasting","volume":"20","author":"Thomas","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"764346","DOI":"10.3389\/fmed.2021.764346","article-title":"Muscle Physiopathology in Parathyroid Hormone Disorders","volume":"8","author":"Romagnoli","year":"2021","journal-title":"Front. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrneph.2015.207","article-title":"Chronic kidney disease: Role of PTH\/PTHrP receptor in cachexia","volume":"12","author":"Allison","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chen, J.H., and Chiang, C.K. (2021). Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence. Toxins, 14.","DOI":"10.3390\/toxins14010008"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chao, C.T., and Lin, S.H. (2021). Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126270"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1523-1755.2004.00354.x","article-title":"Characterization of uremic toxin transport by organic anion transporters in the kidney","volume":"65","author":"Deguchi","year":"2004","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfs133","article-title":"p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lu, C.L., Liao, C.H., Lu, K.C., and Ma, M.C. (2020). TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176212"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/ars.2015.6310","article-title":"Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy","volume":"24","author":"Lee","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-139X.2005.18313.x","article-title":"Uremic toxins: A new focus on an old subject","volume":"18","author":"Yavuz","year":"2005","journal-title":"Semin. Dial."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1373\/49.3.470","article-title":"Toxicity of free p-cresol: A prospective and cross-sectional analysis","volume":"49","author":"Brunet","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1046\/j.1523-1755.2003.00310.x","article-title":"Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms","volume":"64","author":"Bammens","year":"2003","journal-title":"Kidney Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Poesen, R., Viaene, L., Verbeke, K., Augustijns, P., Bammens, B., Claes, K., Kuypers, D., Evenepoel, P., and Meijers, B. (2014). Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease. BMC Nephrol., 15.","DOI":"10.1186\/1471-2369-15-87"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bone.2009.02.019","article-title":"Dioxins interfere with differentiation of osteoblasts and osteoclasts","volume":"44","author":"Korkalainen","year":"2009","journal-title":"Bone"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: An environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature05683","article-title":"Dioxin receptor is a ligand-dependent E3 ubiquitin ligase","volume":"446","author":"Ohtake","year":"2007","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cotox.2017.01.001","article-title":"Canonical and non-canonical aryl hydrocarbon receptor signaling pathways","volume":"2","author":"Wright","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/JME-22-0076","article-title":"Aryl hydrocarbon receptor (AhR)-mediated signaling as a critical regulator of skeletal cell biology","volume":"69","author":"Alhamad","year":"2022","journal-title":"J. Mol. Endocrinol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: Disease and healthy States","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40620-017-0406-x","article-title":"Uremic Toxicity and Bone in CKD","volume":"30","author":"Yamamoto","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"589752","DOI":"10.3389\/fcell.2020.589752","article-title":"The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?","volume":"8","author":"Mo","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Liu, W.C., Tomino, Y., and Lu, K.C. (2018). Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120. Toxins, 10.","DOI":"10.3390\/toxins10090367"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jre.12355","article-title":"Benzo[a]pyrene\/aryl hydrocarbon receptor signaling inhibits osteoblastic differentiation and collagen synthesis of human periodontal ligament cells","volume":"51","author":"Monnouchi","year":"2016","journal-title":"J. Periodontal Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/intimm\/dxt011","article-title":"The roles of aryl hydrocarbon receptor in immune responses","volume":"25","author":"Nguyen","year":"2013","journal-title":"Int. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.taap.2013.09.002","article-title":"New insights to the role of aryl hydrocarbon receptor in bone phenotype and in dioxin-induced modulation of bone microarchitecture and material properties","volume":"273","author":"Herlin","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1359\/jbmr.2001.16.10.1812","article-title":"Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on bone in two rat strains with different aryl hydrocarbon receptor structures","volume":"16","author":"Jamsa","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.taap.2014.08.025","article-title":"The aryl hydrocarbon receptor suppresses osteoblast proliferation and differentiation through the activation of the ERK signaling pathway","volume":"280","author":"Yu","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1073\/pnas.1220919110","article-title":"Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes","volume":"110","author":"Iqbal","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bcp.2005.04.028","article-title":"Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration","volume":"70","author":"Voronov","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.envint.2018.08.051","article-title":"The Seveso accident: A look at 40 years of health research and beyond","volume":"121","author":"Eskenazi","year":"2018","journal-title":"Environ. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1289\/ehp.6920","article-title":"Developmental dental aberrations after the dioxin accident in Seveso","volume":"112","author":"Alaluusua","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1289\/ehp.1306788","article-title":"Serum dioxin concentrations and bone density and structure in the Seveso Women\u2019s Health Study","volume":"122","author":"Eskenazi","year":"2014","journal-title":"Environ. Health Perspect."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1289\/ehp.11781","article-title":"Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding","volume":"117","author":"Milbrath","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3389\/fphys.2017.00836","article-title":"Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease","volume":"8","author":"Kalaska","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kim, S.Y., Oh, Y., Jo, S., Ji, J.D., and Kim, T.H. (2021). Inhibition of Human Osteoclast Differentiation by Kynurenine through the Aryl-Hydrocarbon Receptor Pathway. Cells, 10.","DOI":"10.3390\/cells10123498"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Yu, T.Y., Pang, W.J., and Yang, G.S. (2015). Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117112"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000476074","article-title":"Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins","volume":"137","author":"Brito","year":"2017","journal-title":"Nephron"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephro-vascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J. Ren. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","article-title":"Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells","volume":"63","author":"Motojima","year":"2003","journal-title":"Kidney Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10715762.2015.1125996","article-title":"The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells","volume":"50","author":"Saldanha","year":"2016","journal-title":"Free. Radic. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.jrn.2016.07.005","article-title":"Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease","volume":"26","author":"Borges","year":"2016","journal-title":"J. Ren. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"F1551","DOI":"10.1152\/ajprenal.00281.2004","article-title":"Indoxyl sulfate induces complex redox alterations in mesangial cells","volume":"290","author":"Gelasco","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000112823","article-title":"Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats","volume":"28","author":"Owada","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00424-021-02587-2","article-title":"Correction to: Indoxyl sulfate enhances endothelin-1-induced contraction via impairment of NO\/cGMP signaling in rat aorta","volume":"473","author":"Matsumoto","year":"2021","journal-title":"Pflug. Arch."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/0886022X.2015.1104609","article-title":"Grape seed proanthocyanidin extract protects human umbilical vein endothelial cells from indoxyl sulfate-induced injury via ameliorating mitochondrial dysfunction","volume":"38","author":"Lu","year":"2016","journal-title":"Ren. Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"118807","DOI":"10.1016\/j.lfs.2020.118807","article-title":"Indoxyl sulfate induces ROS production via the aryl hydrocarbon receptor-NADPH oxidase pathway and inactivates NO in vascular tissues","volume":"265","author":"Nakagawa","year":"2021","journal-title":"Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2215\/CJN.05340610","article-title":"Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress","volume":"6","author":"Yu","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000346778","article-title":"Klotho and chronic kidney disease","volume":"180","author":"Hu","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","article-title":"Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation","volume":"81","author":"Sun","year":"2012","journal-title":"Kidney Int."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Dogan, F., and Forsyth, N.R. (2021). Telomerase Regulation: A Role for Epigenetics. Cancers, 13.","DOI":"10.3390\/cancers13061213"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1515\/BC.2008.028","article-title":"Klotho as a regulator of oxidative stress and senescence","volume":"389","year":"2008","journal-title":"Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1073\/pnas.0611079104","article-title":"Amelioration of progressive renal injury by genetic manipulation of Klotho gene","volume":"104","author":"Haruna","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2741\/4889","article-title":"Signaling pathways and effectors of aging","volume":"26","author":"Tabibzadeh","year":"2021","journal-title":"Front. Biosci."},{"key":"ref_85","first-page":"S136","article-title":"Klotho and kidney disease","volume":"23","author":"Hu","year":"2010","journal-title":"J. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.mnh.0000232885.81142.83","article-title":"Klotho as a regulator of fibroblast growth factor signaling and phosphate\/calcium metabolism","volume":"15","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yoshida, T., and Delafontaine, P. (2020). Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 9.","DOI":"10.3390\/cells9091970"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/j.ajkd.2017.01.051","article-title":"Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD","volume":"69","author":"Roshanravan","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-Organ Crosstalk: The Emerging Roles of Myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","article-title":"Muscle, Bone, and Fat Crosstalk: The Biological Role of Myokines, Osteokines, and Adipokines","volume":"18","author":"Kirk","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1172\/JCI94606","article-title":"The many ways of osteoclast activation","volume":"127","author":"Lorenzo","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e00630-16","DOI":"10.1128\/MCB.00630-16","article-title":"A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase","volume":"37","author":"Gralla","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","article-title":"Indoxyl sulphate inhibits osteoclast differentiation and function","volume":"27","author":"Mozar","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Park, R., Madhavaram, S., and Ji, J.D. (2020). The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function. Cells, 9.","DOI":"10.3390\/cells9102294"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/toxsci\/kfp284","article-title":"Transgenic mice with a constitutively active aryl hydrocarbon receptor display a gender-specific bone phenotype","volume":"114","author":"Wejheden","year":"2010","journal-title":"Toxicol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/2211-5463.12258","article-title":"Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption","volume":"7","author":"Watanabe","year":"2017","journal-title":"FEBS Open. Bio"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1172\/JCI89632","article-title":"Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure","volume":"128","author":"Tampe","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0303-7207(03)00151-5","article-title":"Transcriptional regulation of the human Runx2\/Cbfa1 gene promoter by bone morphogenetic protein-7","volume":"205","author":"Tou","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jcb.21249","article-title":"Mechanical stress-mediated Runx2 activation is dependent on Ras\/ERK1\/2 MAPK signaling in osteoblasts","volume":"101","author":"Kanno","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bone.2015.07.015","article-title":"Altered material properties are responsible for bone fragility in rats with chronic kidney injury","volume":"81","author":"Iwasaki","year":"2015","journal-title":"Bone"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/sj.ki.5001600","article-title":"Insufficiency of PTH action on bone in uremia","volume":"70","author":"Iwasaki","year":"2006","journal-title":"Kidney Int. Suppl."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","article-title":"CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies","volume":"278","author":"Reiss","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","article-title":"Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease","volume":"57","author":"Iwasaki","year":"2013","journal-title":"Bone"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/joim.12361","article-title":"How to predict and treat increased fracture risk in chronic kidney disease","volume":"278","author":"West","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/j.ajkd.2013.12.018","article-title":"Bone disease in CKD: A focus on osteoporosis diagnosis and management","volume":"64","author":"Miller","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5935\/0101-2800.20140042","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J. Bras. Nefrol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation (2003). K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis., 42, S1\u2013S201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Yamato","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.11.029","article-title":"Pleiotropic effects of vitamin D in chronic kidney disease","volume":"453","author":"Liu","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/toxins5081475","article-title":"Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease","volume":"5","author":"Tsujimoto","year":"2013","journal-title":"Toxins"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fmed.2020.00178","article-title":"Transcriptome Profiling Reveals Indoxyl Sulfate Should Be Culpable of Impaired T Cell Function in Chronic Kidney Disease","volume":"7","author":"Xiang","year":"2020","journal-title":"Front. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/toxins6030934","article-title":"The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: A new concept to understand cardiovascular complications of chronic kidney disease","volume":"6","author":"Sallee","year":"2014","journal-title":"Toxins"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1073\/pnas.0804231105","article-title":"Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells","volume":"105","author":"Kimura","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2015.08.011","article-title":"Vitamin D and immune function in chronic kidney disease","volume":"450","author":"Liu","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"865546","DOI":"10.3389\/fimmu.2022.865546","article-title":"Bone Morphogenetic Proteins Shape Treg Cells","volume":"13","author":"Kraj","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/ndt\/gfaa129","article-title":"Myostatin and muscle atrophy during chronic kidney disease","volume":"36","author":"Bataille","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Lu, C.L., Zheng, C.M., Lu, K.C., Liao, M.T., Wu, K.L., and Ma, M.C. (2021). Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease. Antioxidants, 10.","DOI":"10.3390\/antiox10060936"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e145475","DOI":"10.1172\/jci.insight.145475","article-title":"Indoxyl sulfate reduces Ito,f by activating ROS\/MAPK and NF-kappaB signaling pathways","volume":"7","author":"Yang","year":"2022","journal-title":"JCI Insight"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"36618","DOI":"10.1038\/srep36618","article-title":"Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"p-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1152\/ajprenal.00117.2021","article-title":"Skeletal myopathy in CKD: A comparison of adenine-induced nephropathy and 5\/6 nephrectomy models in mice","volume":"321","author":"Kim","year":"2021","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/ijn.ijn_445_21","article-title":"Uremic Sarcopenia","volume":"32","author":"Mohanasundaram","year":"2022","journal-title":"Indian. J. Nephrol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Nishi, H., Takemura, K., Higashihara, T., and Inagi, R. (2020). Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach. Nutrients, 12.","DOI":"10.3390\/nu12061814"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gft070","article-title":"Uraemic sarcopenia: Aetiology and implications","volume":"29","author":"Fahal","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2008.04.007","article-title":"Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients","volume":"27","author":"Carrero","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2215\/CJN.09200913","article-title":"Associations of body size and body composition with functional ability and quality of life in hemodialysis patients","volume":"9","author":"Martinson","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijcard.2018.03.064","article-title":"Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease","volume":"268","author":"Hanatani","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1248\/bpb.b19-00513","article-title":"Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions","volume":"42","author":"Watanabe","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1128S","DOI":"10.3945\/ajcn.2010.28608B","article-title":"Review of muscle wasting associated with chronic kidney disease","volume":"91","author":"Workeneh","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI118499","article-title":"Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect","volume":"97","author":"Ding","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1681\/ASN.2009060571","article-title":"Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy","volume":"21","author":"Zhang","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jcsm.12802","article-title":"Primary skeletal muscle cells from chronic kidney disease patients retain hallmarks of cachexia in vitro","volume":"13","author":"Baker","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/08952841.2019.1697161","article-title":"Advanced glycation end products are associated with sarcopenia in older women: Aging marker dynamics","volume":"33","author":"Eguchi","year":"2021","journal-title":"J. Women Aging"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/jdi.13014","article-title":"Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes","volume":"10","author":"Mori","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","article-title":"Advanced glycation end products in the pathogenesis of chronic kidney disease","volume":"93","author":"Rabbani","year":"2018","journal-title":"Kidney Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3904\/kjim.2022.338","article-title":"Sarcopenia in chronic kidney disease: From bench to bedside","volume":"38","author":"Kim","year":"2023","journal-title":"Korean J. Intern. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI110137","article-title":"Effect of parathyroid hormone on rat heart cells","volume":"67","author":"Bogin","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/srep05066","article-title":"Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation","volume":"4","author":"Kimura","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1985.190","article-title":"Effect of parathyroid hormone on energy metabolism of skeletal muscle","volume":"28","author":"Baczynski","year":"1985","journal-title":"Kidney Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"101480","DOI":"10.1016\/j.molmet.2022.101480","article-title":"Parathyroid hormone (PTH) regulation of metabolic homeostasis: An old dog teaches us new tricks","volume":"60","author":"Rosen","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00223-023-01093-0","article-title":"Metabolic Health and Disease: A Role of Osteokines?","volume":"113","author":"Shimonty","year":"2023","journal-title":"Calcif. Tissue Int."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1023383","DOI":"10.3389\/fmed.2023.1023383","article-title":"Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease","volume":"10","author":"Hou","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jcsm.12874","article-title":"Effects of AST-120 on muscle health and quality of life in chronic kidney disease patients: Results of RECOVERY study","volume":"13","author":"Cha","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1681\/ASN.2014121241","article-title":"The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia","volume":"27","author":"Shivanna","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Liu, W.C., Shyu, J.F., Lim, P.S., Fang, T.C., Lu, C.L., Zheng, C.M., Hou, Y.C., Wu, C.C., Lin, Y.F., and Lu, K.C. (2020). Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103486"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Liu, W.C., Shyu, J.F., Lin, Y.F., Chiu, H.W., Lim, P.S., Lu, C.L., Zheng, C.M., Hou, Y.C., Chen, P.H., and Lu, K.C. (2020). Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor \/MAPK Pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207483"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fendo.2020.00405","article-title":"The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases","volume":"11","author":"Pathak","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"151422","DOI":"10.1016\/j.aanat.2019.151422","article-title":"The osteocyte: A multifunctional cell within the bone","volume":"227","author":"Tresguerres","year":"2020","journal-title":"Ann. Anat."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: An endocrine cell... and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1073\/pnas.1409857112","article-title":"Osteocytes mediate the anabolic actions of canonical Wnt\/beta-catenin signaling in bone","volume":"112","author":"Tu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biocel.2016.05.015","article-title":"The role of the wnt\/beta-catenin signaling pathway in formation and maintenance of bone and teeth","volume":"77 Pt A","author":"Duan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone","volume":"69","author":"Hauschka","year":"1989","journal-title":"Physiol. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Gremminger, V.L., and Phillips, C.L. (2021). Impact of Intrinsic Muscle Weakness on Muscle-Bone Crosstalk in Osteogenesis Imperfecta. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094963"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2017.04.006","article-title":"Molecular bases of the crosstalk between bone and muscle","volume":"115","author":"Karsenty","year":"2018","journal-title":"Bone"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.molmet.2016.07.002","article-title":"Osteocalcin is necessary and sufficient to maintain muscle mass in older mice","volume":"5","author":"Mera","year":"2016","journal-title":"Mol. Metab."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI133572","article-title":"Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts","volume":"130","author":"Chowdhury","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11914-020-00602-6","article-title":"Bone-Muscle Mutual Interactions","volume":"18","author":"Johnson","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1053\/ajkd.2003.50082","article-title":"Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients","volume":"41","author":"Tsubakihara","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ndt\/6.2.105","article-title":"Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients","volume":"6","author":"Niwa","year":"1991","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Amador, A., Campbell, S., Kazantzis, M., Lan, G., Burris, T.P., and Solt, L.A. (2018). Distinct roles for REV-ERBalpha and REV-ERBbeta in oxidative capacity and mitochondrial biogenesis in skeletal muscle. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196787"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"C572","DOI":"10.1152\/ajpcell.00481.2009","article-title":"PGC-1alpha plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscle","volume":"298","author":"Geng","year":"2010","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.12202","article-title":"Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction","volume":"8","author":"Enoki","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0024-3205(99)00410-5","article-title":"Biological effects of resveratrol","volume":"66","author":"Fremont","year":"2000","journal-title":"Life Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e13357","DOI":"10.1111\/asj.13357","article-title":"Regulation of the intestinal barrier by nutrients: The role of tight junctions","volume":"91","author":"Suzuki","year":"2020","journal-title":"Anim. Sci. J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/toxsci\/kfu119","article-title":"Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury","volume":"141","author":"Saito","year":"2014","journal-title":"Toxicol. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Moreira-Pinto, B., Costa, L., Felgueira, E., Fonseca, B.M., and Rebelo, I. (2021). Low Doses of Resveratrol Protect Human Granulosa Cells from Induced-Oxidative Stress. Antioxidants, 10.","DOI":"10.3390\/antiox10040561"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.fertnstert.2020.08.016","article-title":"Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesis","volume":"115","author":"Ragonese","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13018-020-01684-9","article-title":"Resveratrol can enhance osteogenic differentiation and mitochondrial biogenesis from human periosteum-derived mesenchymal stem cells","volume":"15","author":"Moon","year":"2020","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1074\/jbc.275.13.9645","article-title":"Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase","volume":"275","author":"Jaiswal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Filipska, I., Winiarska, A., Knysak, M., and Stompor, T. (2021). Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization. Toxins, 13.","DOI":"10.3390\/toxins13040274"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2215\/CJN.09141209","article-title":"Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease","volume":"5","author":"Balakrishnan","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4162\/nrp.2022.16.2.147","article-title":"Ursolic acid improves the indoxyl sulfate-induced impairment of mitochondrial biogenesis in C2C12 cells","volume":"16","author":"Sasaki","year":"2022","journal-title":"Nutr. Res. Pract."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e74782","DOI":"10.7554\/eLife.74782","article-title":"Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling","volume":"11","author":"Czaya","year":"2022","journal-title":"eLife"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1080\/0886022X.2022.2142140","article-title":"Omega-3 fatty acid and menaquinone-7 combination are helpful for aortic calcification prevention, reducing osteoclast area of bone and Fox0 expression of muscle in uremic rats","volume":"44","author":"Lee","year":"2022","journal-title":"Ren. Fail."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Sanchez-Tocino, M.L., Mas-Fontao, S., Gracia-Iguacel, C., Pereira, M., Gonzalez-Ibarguren, I., Ortiz, A., Arenas, M.D., and Parra, E.G. (2023). A Sarcopenia Index Derived from Malnutrition Parameters in Elderly Haemodialysis Patients. Nutrients, 15.","DOI":"10.3390\/nu15051115"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Noce, A., Marrone, G., Ottaviani, E., Guerriero, C., Di Daniele, F., Pietroboni Zaitseva, A., and Di Daniele, N. (2021). Uremic Sarcopenia and Its Possible Nutritional Approach. Nutrients, 13.","DOI":"10.3390\/nu13010147"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/jcsm.12791","article-title":"Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: A narrative review","volume":"12","author":"Noor","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-021-00898-1","article-title":"Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment","volume":"110","author":"Chatzipetrou","year":"2022","journal-title":"Calcif. Tissue Int."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2076\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:17:42Z","timestamp":1760127462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":182,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["biomedicines11072076"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11072076","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}